| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
04-10-2011, 12:48 PM
|
#1 | ||
|
|||
|
Junior Member
|
This was done in the nineties, albeit rarely, (after activists fought for it) with HIV research. It lead to a different class of anti-viral drugs being in the hands of patients years sooner.
For example, there are multiple a2a receptor antagonists in Phase II and Phase III trials as we speak. This class of drugs will probably be the first approved alternative to dopaminergic treatments in decades. Many of us are trying to navigate PD without sinimet or dopamine agonists. Why are our doctors not permitted to prescribe these investigational drugs for us? Why are there not programs set up for parallel track with the FDA? Debi Brooks? Anyone know the answer to this? Last edited by caldeerster; 04-10-2011 at 01:04 PM. |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| So which "existing" diabetes drug turns the PGC-1 Alpha "Master Switch" back on? | Parkinson's Disease | |||
| Possibly coming to your neighborhood...Ali Center: "Pennies for Parkinson's" campaign | Parkinson's Disease | |||
| NEWS: NEW BOOK..."Surviving Adversity -- living with Parkinson's disease" | Parkinson's Disease | |||
| "Stem Cell Treatment Proven To Reduce Parkinson's Symptoms" | Parkinson's Disease | |||
Why are no investigational Parkinson's drugs being "parallel tracked" with the FDA?
Linear Mode
